RANTES Secretion by Gene-Modified Tumor Cells Results in Loss of TumorigenicityIn Vivo:Role of Immune Cell Subpopulations

Human Gene Therapy - United States
doi 10.1089/hum.1996.7.13-1545
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc

Related search

Prognostic Impact of Immune Gene Expression Signature and Tumor Infiltrating Immune Cells in Localized Clear Cell Renal Cell Carcinoma

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2019English

Loss of Linker Histone H1.0 Marks Self-Renewing Tumor Subpopulations

Cancer Discovery
Oncology
2016English

Immune Regulation of Bone Loss by Th17 Cells

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2008English

Stimulation of Steroid Secretion in Adrenal Tumor Cells by Choleragen

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1973English

Intrapulmonary Administration of CCL21 Gene-Modified Dendritic Cells Reduces Tumor Burden in Spontaneous Murine Bronchoalveolar Cell Carcinoma

Cancer Research
Cancer ResearchOncology
2006English

Cutting Edge: Immediate RANTES Secretion by Resting Memory CD8 T Cells Following Antigenic Stimulation

Journal of Immunology
AllergyImmunology
2003English

Cell Type–specific Immune Phenotypes Predict Loss of Insulin Secretion in New-Onset Type 1 Diabetes

JCI insight
Medicine
2019English

Single-Cell Profiling of Dynamic Cytokine Secretion and the Phenotype of Immune Cells

PLoS ONE
Multidisciplinary
2017English

Prognostic Significance of Tumor Infiltrating Immune Cells in Oral Squamous Cell Carcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy